These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8844397)

  • 21. Mechanisms of mutant p53 stabilization in cancer.
    Frum RA; Grossman SR
    Subcell Biochem; 2014; 85():187-97. PubMed ID: 25201195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells.
    Nakazawa S; Sakata KI; Liang S; Yoshikawa K; Iizasa H; Tada M; Hamada JI; Kashiwazaki H; Kitagawa Y; Yamazaki Y
    Biomed Res; 2019; 40(1):37-49. PubMed ID: 30787262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Chen J; Lin J; Levine AJ
    Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequences.
    Brázdová M; Quante T; Tögel L; Walter K; Loscher C; Tichý V; Cincárová L; Deppert W; Tolstonog GV
    Nucleic Acids Res; 2009 Apr; 37(5):1486-500. PubMed ID: 19139068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant p53 gain of oncogenic function: in vivo evidence, mechanism of action and its clinical implications.
    Adhikari AS; Iwakuma T
    Fukuoka Igaku Zasshi; 2009 Jun; 100(6):217-28. PubMed ID: 19670804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 in recombination and repair.
    Gatz SA; Wiesmüller L
    Cell Death Differ; 2006 Jun; 13(6):1003-16. PubMed ID: 16543940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nuclear matrix as a target for viral and cellular oncogenes.
    Deppert W
    Crit Rev Eukaryot Gene Expr; 2000; 10(1):45-61. PubMed ID: 10813394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Synthetic Approaches towards Small Molecule Reactivators of p53.
    Silva JL; Lima CGS; Rangel LP; Ferretti GDS; Pauli FP; Ribeiro RCB; da Silva TB; da Silva FC; Ferreira VF
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the biological activities of wild-type and mutant p53.
    Zambetti GP; Levine AJ
    FASEB J; 1993 Jul; 7(10):855-65. PubMed ID: 8344485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant p53 proteins bind DNA abnormally in vitro.
    Kern SE; Kinzler KW; Baker SJ; Nigro JM; Rotter V; Levine AJ; Friedman P; Prives C; Vogelstein B
    Oncogene; 1991 Jan; 6(1):131-6. PubMed ID: 1846954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactivation of mutant p53 by capsaicin, the major constituent of peppers.
    Garufi A; Pistritto G; Cirone M; D'Orazi G
    J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UV-induced DNA incision and proliferating cell nuclear antigen recruitment to repair sites occur independently of p53-replication protein A interaction in p53 wild type and mutant ovarian carcinoma cells.
    Riva F; Zuco V; Vink AA; Supino R; Prosperi E
    Carcinogenesis; 2001 Dec; 22(12):1971-8. PubMed ID: 11751427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross talk between stimulated NF-kappaB and the tumor suppressor p53.
    Schneider G; Henrich A; Greiner G; Wolf V; Lovas A; Wieczorek M; Wagner T; Reichardt S; von Werder A; Schmid RM; Weih F; Heinzel T; Saur D; Krämer OH
    Oncogene; 2010 May; 29(19):2795-806. PubMed ID: 20190799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo.
    Timofeev O; Schlereth K; Wanzel M; Braun A; Nieswandt B; Pagenstecher A; Rosenwald A; Elsässer HP; Stiewe T
    Cell Rep; 2013 May; 3(5):1512-25. PubMed ID: 23665223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific and complex interactions of murine p53 with DNA.
    Weissker SN; Müller BF; Homfeld A; Deppert W
    Oncogene; 1992 Oct; 7(10):1921-32. PubMed ID: 1408133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
    Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
    Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Coan M; Toso M; Cesaratto L; Rigo I; Borgna S; Dalla Pietà A; Zandonà L; Iuri L; Zucchetto A; Piazza C; Baldassarre G; Spizzo R; Nicoloso MS
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762037
    [No Abstract]   [Full Text] [Related]  

  • 38. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
    Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
    Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advances on mutant p53 research].
    Li DH; Zhang LQ; He FC
    Yi Chuan; 2008 Jun; 30(6):697-703. PubMed ID: 18550490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 mutations increase resistance to ionizing radiation.
    Lee JM; Bernstein A
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5742-6. PubMed ID: 8516323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.